- CTOTC-08: A multicenter randomized controlled trial of rituximab induction to reduce antibody development and improve outcomes in pediatric lung transplant recipients. Sweet SC, Armstrong B, Blatter J, Chin H, Conrad C, Goldfarb S, Hayes D Jr, Heeger PS, Lyou V, Melicoff-Portillo E, Mohanakumar T, Odim J, Ravichandran R, Schecter M, Storch GA, Visner G, Williams NM, Danziger-Isakov L.Am J Transplant. 2022 Jan;22(1):230-244. doi: 10.1111/ajt.16862. Epub 2021 Nov 5.PMID: 34599540
- Dynamism of the Human Lung Proteome during Alveolarization: Moving beyond the Transcriptome. Alvira CM.Am J Respir Crit Care Med. 2022 Jan 15;205(2):145-147. doi: 10.1164/rccm.202110-2316ED. PMID: 34797738
- Neonatal Coccidioidomycosis: A Single-center Experience and Review of the Literature. Vaughn J, Tablizo MA, Zayed Z, Hepple RR, McCarty JM, Naeem F.Pediatr Infect Dis J. 2022 Feb 1;41(2):151-155. doi: 10.1097/INF.0000000000003281. PMID: 34310505